In AD, the so-called amyloidogenic pathway is active, in which APP is first cleaved by the β-secretase enzyme (BACE) and then by γ-secretase, with the formation of Aβ peptides that aggregate, leading to the formation of neurotoxic prefibrillar oligomers (PFOs) [23]. This evidence concerns the gene APP and Alzheimer disease.